Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

52 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Immunogenicity of two doses of BNT162b2 and mRNA-1273 vaccines for solid cancer patients on treatment with or without a previous SARS-CoV-2 infection.
La Verde N, Riva A, Cona MS, Gabrieli A, Cattaneo M, Fasola C, Lipari G, De Stradis C, Favorito V, Lombardi Stocchetti B, Chizzoniti D, Covizzi A, Rulli E, Galli F, Ruggieri L, Gambaro A, Ferrario S, Dalu D, Tarkowski MS. La Verde N, et al. Among authors: ruggieri l. Int J Cancer. 2023 Feb 15;152(4):661-671. doi: 10.1002/ijc.34273. Epub 2022 Sep 28. Int J Cancer. 2023. PMID: 36056571 Free PMC article.
Clinical efficacy of the first two doses of anti-SARS-CoV-2 mRNA vaccines in solid cancer patients.
Cona MS, Riva A, Dalu D, Gabrieli A, Fasola C, Lipari G, Pozza G, Rulli E, Galli F, Ruggieri L, Masedu E, Parma G, Chizzoniti D, Gambaro A, Ferrario S, Antista M, De Monte M, Tarkowski MS, La Verde N. Cona MS, et al. Among authors: ruggieri l. Cancer Med. 2023 Jun;12(12):12967-12974. doi: 10.1002/cam4.5968. Epub 2023 Apr 28. Cancer Med. 2023. PMID: 37114577 Free PMC article.
Antibody response to three-dose anti-SARS-CoV-2 mRNA-vaccination in treated solid cancer patients.
Dalu D, Tarkowski M, Ruggieri L, Cona MS, Gabrieli A, De Francesco D, Fasola C, Ferrario S, Gambaro A, Masedu E, Parma G, Rulli E, De Stradis C, Mavilio D, Calcaterra F, Manoni F, Riva A, La Verde N. Dalu D, et al. Among authors: ruggieri l. Int J Cancer. 2024 Apr 15;154(8):1371-1376. doi: 10.1002/ijc.34817. Epub 2023 Dec 15. Int J Cancer. 2024. PMID: 38100252
Association of Steroids use with Survival in Patients Treated with Immune Checkpoint Inhibitors: A Systematic Review and Meta-Analysis.
Petrelli F, Signorelli D, Ghidini M, Ghidini A, Pizzutilo EG, Ruggieri L, Cabiddu M, Borgonovo K, Dognini G, Brighenti M, De Toma A, Rijavec E, Garassino MC, Grossi F, Tomasello G. Petrelli F, et al. Among authors: ruggieri l. Cancers (Basel). 2020 Feb 27;12(3):546. doi: 10.3390/cancers12030546. Cancers (Basel). 2020. PMID: 32120803 Free PMC article. Review.
The role of surgery in recurrent ependymomas.
Aldave G, Okcu MF, Ruggieri L, Paulino AC, McGovern S, Whitehead W, Weiner HL, Chintagumpala M. Aldave G, et al. Among authors: ruggieri l. J Neurosurg Pediatr. 2023 Sep 1;32(5):584-589. doi: 10.3171/2023.7.PEDS2373. Print 2023 Nov 1. J Neurosurg Pediatr. 2023. PMID: 37657117
Different facets of the same niche: Integrating citizen science and scientific survey data to predict biological invasion risk under multiple global change drivers.
Di Febbraro M, Bosso L, Fasola M, Santicchia F, Aloise G, Lioy S, Tricarico E, Ruggieri L, Bovero S, Mori E, Bertolino S. Di Febbraro M, et al. Among authors: ruggieri l. Glob Chang Biol. 2023 Oct;29(19):5509-5523. doi: 10.1111/gcb.16901. Epub 2023 Aug 7. Glob Chang Biol. 2023. PMID: 37548610
52 results